Literature DB >> 20161011

New Approach to 4-Phenyl-β-aminotetralin from 4-(3-Halophenyl)tetralen-2-ol Phenylacetate.

Adam S Vincek1, Raymond G Booth.   

Abstract

Mixed trifluoroacetyl phenylacetyl anhydride and 3-halostyrenes (fluoro, chloro, and bromo) or vinylcycloalkanes (cyclohexyl, cyclooctyl), undergo cascade Friedel-Crafts cycli-acylalkylation, enolization, and O-acylation to give 4-substituted tetralen-2-ol phenylacetates, without additional solvent in good yields. Base alcoholysis of 4-phenyltetralen-2-ol phenylacetate reveals the tetral-2-one for asymmetric transfer hydrogenation. Bromophenyltetralen-2-ol phenylacetate undergoes Suzuki coupling, and provides a short route to trans-4-phenyl-β-aminotetralin.

Entities:  

Year:  2009        PMID: 20161011      PMCID: PMC2758692          DOI: 10.1016/j.tetlet.2009.06.099

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  11 in total

1.  Organic chemistry: Molecular diversity by design.

Authors:  Stuart L Schreiber
Journal:  Nature       Date:  2009-01-08       Impact factor: 49.962

2.  A Highly Active Catalyst for the Room-Temperature Amination and Suzuki Coupling of Aryl Chlorides.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-08       Impact factor: 15.336

3.  General synthesis of 8-aryl-2-tetralones.

Authors:  M Carmen Carreño; Marcos Gonzalez-López; Alfonso Latorre; Antonio Urbano
Journal:  J Org Chem       Date:  2006-06-23       Impact factor: 4.354

4.  Enantioselective RH-catalyzed hydrogenation of enol acetates and enol carbamates with monodentate phosphoramidites.

Authors:  Lavinia Panella; Ben L Feringa; Johannes G de Vries; Adriaan J Minnaard
Journal:  Org Lett       Date:  2005-09-15       Impact factor: 6.005

5.  Clean-chemistry synthesis of 2-tetralones in a single-stage acylation-cycloalkylation process.

Authors:  A D Gray; T P Smyth
Journal:  J Org Chem       Date:  2001-10-19       Impact factor: 4.354

6.  Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.

Authors:  Ola M Ghoneim; Jacqueline A Legere; Alexander Golbraikh; Alexander Tropsha; Raymond G Booth
Journal:  Bioorg Med Chem       Date:  2006-06-16       Impact factor: 3.641

7.  Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice.

Authors:  Neil E Rowland; Erica M Crump; Nancy Nguyen; Kimberly Robertson; Zhuming Sun; Raymond G Booth
Journal:  Pharmacol Biochem Behav       Date:  2008-07-19       Impact factor: 3.533

8.  An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT(2) melatonin receptor antagonist.

Authors:  Simone Lucarini; Annalida Bedini; Gilberto Spadoni; Giovanni Piersanti
Journal:  Org Biomol Chem       Date:  2007-11-13       Impact factor: 3.876

9.  Conformation by NMR of two tetralin-based receptor ligands.

Authors:  Giuseppe Gatti; Giovanni Piersanti; Gilberto Spadoni
Journal:  Farmaco       Date:  2003-07

10.  Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.

Authors:  S D Wyrick; R G Booth; A M Myers; C E Owens; N S Kula; R J Baldessarini; A T McPhail; R B Mailman
Journal:  J Med Chem       Date:  1993-08-20       Impact factor: 7.446

View more
  8 in total

1.  A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.

Authors:  Clinton E Canal; Drake Morgan; Daniel Felsing; Krishnakanth Kondabolu; Neil E Rowland; Kimberly L Robertson; Rajeev Sakhuja; Raymond G Booth
Journal:  J Pharmacol Exp Ther       Date:  2014-02-21       Impact factor: 4.030

2.  Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens.

Authors:  James M Kasper; Raymond G Booth; Joanna Peris
Journal:  Synapse       Date:  2014-11-20       Impact factor: 2.562

3.  Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors.

Authors:  Rajeev Sakhuja; Krishnakanth Kondabolu; Tania Córdova-Sintjago; Sean Travers; Adam S Vincek; Myong Sang Kim; Khalil A Abboud; Lijuan Fang; Zhuming Sun; Clinton E Canal; Raymond G Booth
Journal:  Bioorg Med Chem       Date:  2015-02-07       Impact factor: 3.641

4.  The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats.

Authors:  James Kasper; Rajiv Tikamdas; Myong Sang Kim; Kaley Macfadyen; Richard Aramini; Joseph Ladd; Sarah Bisceglia; Raymond Booth; Joanna Peris
Journal:  Eur J Pharmacol       Date:  2013-09-13       Impact factor: 4.432

5.  Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.

Authors:  Clinton E Canal; Raymond G Booth; Drake Morgan
Journal:  Neuropharmacology       Date:  2013-01-23       Impact factor: 5.250

6.  Aromatic interactions impact ligand binding and function at serotonin 5-HT2C G protein-coupled receptors: Receptor homology modeling, ligand docking, and molecular dynamics results validated by experimental studies.

Authors:  Tania Córdova-Sintjago; Nancy Villa; Lijuan Fang; Raymond G Booth
Journal:  Mol Phys       Date:  2014-01-01       Impact factor: 1.962

7.  Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications.

Authors:  Drake Morgan; Krishnakanth Kondabolu; Allison Kuipers; Rajeev Sakhuja; Kimberly L Robertson; Neil E Rowland; Raymond G Booth
Journal:  Neuropharmacology       Date:  2013-05-09       Impact factor: 5.250

8.  Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.

Authors:  Clinton E Canal; Tania Cordova-Sintjago; Yue Liu; Myong S Kim; Drake Morgan; Raymond G Booth
Journal:  J Pharmacol Exp Ther       Date:  2013-09-30       Impact factor: 4.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.